IP Library Granted Patent US 7,259,275
Granted Patent B2
US 7,259,275 · App. 11/290,328 · Granted Aug 21, 2007

Method for preparing curable amide gellant compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,259,275
App. No.
11/290,328
Granted
Aug 21, 2007
Kind
B2
Abstract

Disclosed is a process for preparing a compound of the formula wherein R 1 is an alkyl group having at least one ethylenic unsaturation, an arylalkyl group having at least one ethylenic unsaturation, or an alkylaryl group having at least one ethylenic unsaturation, R 2 and R 3 each, independently of the others, are alkylene groups, arylene groups, arylalkylene groups, or alkylarylene groups, and n is an integer representing the number of repeat amide units and is at least 1, said process comprising: (a) reacting a diacid of the formula HOOC—R 2 —COOH with a diamine of the formula in the absence of a solvent while removing water from the reaction mixture to form an acid-terminated oligoamide intermediate; and (b) reacting the acid-terminated oligoamide intermediate with a monoalcohol of the formula R 1 —OH in the presence of a coupling agent and a catalyst to form the product.

Claims (38)

1. A process for preparing a compound of the formula

wherein R 1 is (i) an alkyl group having at least one ethylenic unsaturation therein, including linear and branched, cyclic and acyclic, and substituted and unsubstituted alkyl groups, and wherein hetero atoms either may or may not be present in the alkyl group, (ii) an arylalkyl group having at least one ethylenic unsaturation therein, including substituted and unsubstituted arylalkyl groups, wherein the alkyl portion of the arylalkyl group can be linear or branched, cyclic or acyclic, and substituted or unsubstituted, and wherein hetero atoms either may or may not be present in either the aryl or the alkyl portion of the arylalkyl group, or (iii) an alkylaryl group having at least one ethylenic unsaturation therein, including substituted and unsubstituted alkylaryl groups, wherein the alkyl portion of the alkylaryl group can be linear or branched, cyclic or acyclic, and substituted or unsubstituted, and wherein hetero atoms either may or may not be present in either the aryl or the alkyl portion of the alkylaryl group, R 2 and R 3 each, independently of the others, are (i) alkylene groups, including linear and branched, saturated and unsaturated, cyclic and acyclic, and substituted and unsubstituted alkylene groups, and wherein hetero atoms either may or may not be present in the alkylene group, (ii) arylene groups, including substituted and unsubstituted arylene groups, and wherein hetero atoms either may or may not be present in the arylene group, (iii) arylalkylene groups, including substituted and unsubstituted arylalkylene groups, wherein the alkyl portion of the arylalkylene group can be linear or branched, saturated or unsaturated, cyclic or acyclic, and substituted or unsubstituted, and wherein hetero atoms either may or may not be present in either the aryl or the alkyl portion of the arylalkylene group, or (iv) alkylarylene groups, including substituted and unsubstituted alkylarylene groups, wherein the alkyl portion of the alkylarylene group can be linear or branched, saturated or unsaturated, cyclic or acyclic, and substituted or unsubstituted, and wherein hetero atoms either may or may not be present in either the aryl or the alkyl portion of the alkylarylene group, and n is an integer representing the number of repeat amide units and is at least 1, said process comprising: (a) reacting a diacid of the formula

HOOC—R 2 —COOH

with a diamine of the formula

in the absence of a solvent while removing water from the reaction mixture to form an acid-terminated oligoamide intermediate of the formula

and (b) reacting the acid-terminated oligoamide intermediate with a monoalcohol of the formula

R 1 —OH

in the presence of a coupling agent and a catalyst to form the product of the formula

2. A process according to claim 1 wherein about n+1 molar equivalents of the diacid and from about 0.75 n to about 1.5 n molar equivalents of the diamine are reacted to form the oligoamide intermediate.

3. A process according to claim 1 wherein the reaction between the diacid and the diamine to form the oligoamide intermediate is carried out at a temperature of at least about 130° C., and wherein the reaction between the diacid and the diamine to form the oligoamide intermediate is carried out at a temperature of no more than about 180° C.

4. A process according to claim 1 wherein the reaction between the diacid and the diamine to form the oligoamide intermediate is carried out for at least about 2 hours.

5. A process according to claim 1 wherein the coupling agent is 1,3-dicyclohexylcarbodiimide, 1-[3-(dimethylamino)propyl]3-ethylcarbodiimide HCl, N,N-carbonyldiimidazole, N-cyclohexyl-N′-(2-morpholinoethyl)-carbodiimide methyl-p-toluenesulfonate, (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate, (o-benzotriazol-1-yl)-N,N,N′,N′-bis(tetramethylene)uronium hexafluorophosphate, bis(2-oxo-3-oxazolidinyl)phosphonic chloride, (1H-1,2,3-benzotriazol-1-yloxy)tris(pyrrolidino)phosphonium hexafluorophosphate, or mixtures thereof.

6. A process according to claim 1 wherein the catalyst is 4-dimethylaminopyridine, triethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, or mixtures thereof.

7. A process according to claim 1 wherein the oligoamide intermediate and the monoalcohol are present in relative amounts of at least about 2 moles of monoalcohol per every 1 mole of oligoamide intermediate.

8. A process according to claim 1 wherein the oligoamide intermediate and the coupling agent are present in relative amounts of at least about 1.8 moles of coupling agent per every 1 mole of oligoamide intermediate.

9. A process according to claim 1 wherein the oligoamide intermediate and the catalyst are present in relative amounts of at least about 0.05 mole of catalyst per every 1 mole of oligoamide intermediate.

10. A process according to claim 1 wherein the reaction between the oligoamide intermediate and the monoalcohol is carried out at a temperature of at least about 15° C., and wherein the reaction between the oligoamide intermediate and the monoalcohol is carried out at a temperature of no more than about 50° C.

11. A process according to claim 1 wherein the reaction between the oligoamide intermediate and the monoalcohol is carried out for a period of at least about 2.5 hours.

12. A process according to claim 1 wherein R 1 is an alkyl group having at least one ethylenic unsaturation therein, including linear and branched, cyclic and acyclic, and substituted and unsubstituted alkyl groups, and wherein hetero atoms either may or may not be present in the alkyl group.

13. A process according to claim 12 wherein the alkyl group is an unsubstituted alkyl group.

14. A process according to claim 1 wherein R 1 is of the formula

wherein m is an integer representing the number of repeating [O—(CH 2 ) 2 ] units.

15. A process according to claim 1 wherein R 2 is an alkylene group, including linear and branched, saturated and unsaturated, cyclic and acyclic, and substituted and unsubstituted alkylene groups, and wherein hetero atoms either may or may not be present in the alkylene group.

16. A process according to claim 15 wherein the alkylene group is a saturated unsubstituted alkylene group.

17. A process according to claim 1 wherein R 2 is an alkylene group of the formula —C 34 H 56+a — and are branched alkylene groups which may include unsaturations and cyclic groups, wherein a is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1, or 12.

18. A process according to claim 17 wherein R 2 includes isomers of the formula

19. A process according to claim 1 wherein R 3 is an alkylene group, including linear and branched, saturated and unsaturated, cyclic and acyclic, and substituted and unsubstituted alkylene groups, and wherein hetero atoms either may or may not be present in the alkylene group.

20. A process according to claim 19 wherein the alkylene group is a saturated unsubstituted alkylene group.

21. A process according to claim 1 wherein R 3 is a —CH 2 CH 2 — group.

22. A process according to claim 1 wherein n is no more than about 20.

23. A process according to claim 1 wherein n is 1 or 2.

24. A process according to claim 1 wherein the compound is of the formula

wherein —C 34 H 56+a — represents a branched alkylene group which may include unsaturations and cyclic groups, wherein a is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 and wherein n is 1 or 2.

25. A process according to claim 1 wherein the compound is of the formula

26. A process according to claim 1 wherein the compound is of the formula

or mixtures thereof, wherein —C 34 H 56+a — represents a branched alkylene group which may include unsaturations and cyclic groups, wherein a is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, n is 1 or 2, and m is an integer representing the number of repeating [O—(CH 2 ) 2 ] units.

27. A process according to claim 1 wherein the compound is of the formula

or mixtures thereof, wherein n is 1 or 2 and m is an integer representing the number of repeating [O—(CH 2 ) 2 ] units.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
RELEASE OF SECURITY INTEREST IN PATENTS AT R/F 062740/0214 Recorded May 18, 2023
From: CITIBANK, N.A., AS AGENT
To: XEROX CORPORATION
Reel/Frame 063694/0122 →
SECURITY INTEREST Recorded Nov 10, 2022
From: XEROX CORPORATION
To: CITIBANK, N.A., AS AGENT
Reel/Frame 062740/0214 →